HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masato Shimojo Selected Research

N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamide

8/2013Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
1/2012Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
1/2012Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masato Shimojo Research Topics

Disease

4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2013 - 05/2009
3Infarction (Infarctions)
08/2013 - 01/2012
2Pain (Aches)
02/2014 - 01/2013
2Ischemic Stroke
08/2013 - 01/2012
2Hypothermia
01/2012 - 05/2009
1Catalepsy
11/2017
1Schizophrenia (Dementia Praecox)
11/2017
1Neurobehavioral Manifestations
11/2017
1Cerebral Infarction
08/2013
1Brain Ischemia (Cerebral Ischemia)
08/2013
1Atrophy
01/2012
1Ischemia
05/2009

Drug/Important Bio-Agent (IBA)

3N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamideIBA
08/2013 - 01/2012
2PiperazineIBA
02/2014 - 01/2013
2fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
02/2014 - 01/2013
2Cannabinoid Receptor AgonistsIBA
08/2013 - 01/2012
2Neuroprotective AgentsIBA
01/2012 - 05/2009
1Antipsychotic Agents (Antipsychotics)IBA
11/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2017
1Analgesics (Analgesic Drugs)IBA
02/2014
1Tissue Plasminogen Activator (Alteplase)FDA Link
08/2013
1triphenyltetrazoliumIBA
08/2013
1Excitatory Amino AcidsIBA
01/2012
1Glutamic Acid (Glutamate)FDA Link
01/2012
1AM 251 (AM251)IBA
01/2012
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2012
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
05/2009
1Messenger RNA (mRNA)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009

Therapy/Procedure

1Thrombolytic Therapy
08/2013
1Sutures (Suture)
01/2012